Naresh Mendiratta - Representative key publications: 1. AE9C90CB: A Novel Muscarinic Receptor Antagonist for the treatment of overactive bladder, British Jr of Pharmacology, 2010, in press 2

Version 1

      Publication Details (including relevant citation   information): Representative key publications: 1.   AE9C90CB: A Novel Muscarinic Receptor Antagonist for the   treatment of overactive bladder, British Jr of Pharmacology,   2010, in press 2. Comparative in vivo uroselectivity profiles of   anticholinergics, tested in a novel anesthetized rabbit model,   European Jr. of Pharmacology, 2007, 572(2-3), 207-12 3.Synthesis   and optimization of novel and selective muscarinic M3 receptor   antagonists, Bioorganic and Medicinal Chemistry Letters, 2007,   17, 5256-60. 4. Design, synthesis and activity of novel   derivatives of Oxybutynin and Tolterodine, Bioorganic and   Medicinal Chemistry Letters, 15, 2005, 2093-96. 5. Approaches to   the stereoselective total synthesis of biologically natural   products, Pure and Applied Chemistry, 77(1), 2005, 103-17. 6.   Total synthesis of pamamycin-607: application of remote   asymmetric induction in organic synthesis, Tet. Lett., 42, 2001,   4969-74. 7. Polyphenols and alkaloids from Piper species,   Phytochemistry, 49, 1998, 1069. 8. Anti-invasive activity of   alkaloids and polyphenolics in vitro, Bioorganic and Medicinal   Chemistry, 5, 1997, 1609. 9. Schiff bases of amino acid esters as   new substrates for the enantioselective enzymatic hydrolysis and   accompanied asymmetric transformation, Jr. of Organic chemistry,   61, 1996, 1223-27. PLUS Ten more publication PATENTS WO   2009/156966A1, WO 2008/041184, WO 2008/029349, WO 2007/110782, WO   2007/0077510, WO 2007/039884, WO 2007/007281, WO 2007/007282, WO   2006/035280, WO 2006/054162A1, WO 2006/035303, WO 2006/117754, WO   2006/064304A1, WO 2004/005252, WO 2004/067510, WO 2004/069835, WO   2004/089364 and WO 2004/089900.

      Abstract: null

      Address (URL):